Exploring the therapeutic applications of metformin in articular cartilage repair: mechanistic insights and translational perspectives.

Authors

Pan Jin, Xiaoxue Xin, Wei Liu, Xiaochi Zhu, Zengkun Li, Xiuhong Cao, Ziying Meng, Xiao Tian, Jiaxin Chen, Lixue Zou, Fabiao Yu, Tongmeng Jiang

Published in

Frontiers in immunology. Volume 17. Pages 1916957. Epub Aug 28, 2026.

Abstract

Articular cartilage is characterized by an avascular structure and limited intrinsic regenerative capacity. The most prevalent pathological conditions that lead to cartilage damage are osteoarthritis (OA) and rheumatoid arthritis (RA). In recent decades, cartilage homeostasis has been shown to be particularly vulnerable to metabolic disturbances, especially those induced by obesity and diabetes mellitus. Metformin, a first-line antidiabetic agent and emerging antiaging therapeutic, has garnered significant attention as a promising candidate for cartilage repair that can address the unmet clinical need for treating currently irreversible cartilage damage and associated pathologies such as OA and RA. This review synthesizes preclinical and clinical evidence to elucidate the multifaceted effects of metformin on cartilage homeostasis. Cellular and animal studies have demonstrated that metformin exerts chondroprotective effects through multiple complementary mechanisms, including the activation of AMPK/SIRT1-mediated autophagy, the suppression of NF-κB signaling, the inhibition of matrix-degrading enzymes, the reduction of oxidative stress and inflammatory mediators, the modulation of macrophage polarization toward an anti-inflammatory phenotype, and the attenuation of aberrant subchondral bone remodeling. Emerging clinical evidence suggests that metformin may attenuate OA progression and ameliorate clinical symptoms. However, further large-scale, prospective trials are warranted to confirm its translation potential. By integrating findings across experimental models and clinical observations, this review highlights the role of metformin in modulating chondrocyte metabolism, mitigating inflammatory cascades, and promoting cartilage repair, thereby offering novel therapeutic strategies for cartilage-related disorders.

PMID:
42729817
Bibliographic data and abstract were imported from PubMed on 18 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.